News | FDA Approves Genentech’s Susvimo for Treating Wet AMD

FDA Approves Ranibizumab Ocular Implant for Age-Related Macular Degeneration [AMD]Подробнее

SUSVIMO: Port Delivery System for wet AMDПодробнее

FDA approves faricimab (Vabysmo) for macular degeneration #AMD & diabetic macular edema #DME . #medПодробнее

FDA approves Biogen's Alzheimer's drugПодробнее

CBS Austin: New Implant Helps Restore Eyesight | Austin Retina Associates | Macular DegenerationПодробнее

FDA approves Biogen Alzheimer's treatmentПодробнее

Wills Eye Hospital Leads Research For Recently FDA-Approved Treatment For Eye Disease, Macular DegenПодробнее

Carl Awh, MD on the Reintroduction of #Susvimo for Wet #AMD After a Voluntary Recall #ASRS #retinaПодробнее

FDA approves controversial Biogen Alzheimer's drug | DW NewsПодробнее

FDA issues warning about DELSAM Pharma's Artificial Eye OintmentПодробнее

An FDA approval could be worth over $100 billion to this biotech stockПодробнее

FDA approves Novartis gene therapy for rare genetic disorderПодробнее

FDA Approves UnituxinПодробнее

FDA approves controversial Alzheimer's drugПодробнее

New drug to treat Macular Degeneration is now available at The Eye Associates.Подробнее

FDA unveils new rules for mammogramsПодробнее

FDA narrows patient group for Biogen's Alzheimer's drugПодробнее

FDA approves promising new alzheimer's drugПодробнее

FDA approves Biogen Alzheimer's drug, first new therapy for the disease in nearly two decadesПодробнее